Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2013 | 03-2012 | 12-2011 | 03-2011 | 12-2010 | |
| Sales | 670,950 | 145,140 | 0 | 107,720 | 0 |
| Cost of Goods | 176,120 | 45,970 | N/A | 44,610 | N/A |
| Gross Profit | 494,820 | 99,170 | N/A | 63,110 | N/A |
| Operating Expenses | 166,350 | 33,910 | 0 | 30,320 | 0 |
| Operating Income | 328,600 | 66,230 | N/A | 33,400 | N/A |
| Interest Expense | 0 | 0 | 0 | 770 | 0 |
| Other Income | 7,260 | -1,110 | 0 | -180 | 0 |
| Pre-tax Income | 335,860 | 65,120 | 0 | 32,450 | 0 |
| Income Tax | 67,790 | 17,790 | N/A | 6,360 | N/A |
| Net Income Continuous | 289,045 | 183,623 | N/A | 52,398 | N/A |
| Net Income Discontinuous | -1,190 | 60 | N/A | -130 | N/A |
| Net Income | $266,870 | $47,400 | $N/A | $25,950 | $N/A |
| EPS Basic Total Ops | 5.96 | 4.11 | N/A | 1.33 | N/A |
| EPS Basic Continuous Ops | 6.47 | 4.14 | N/A | 1.33 | N/A |
| EPS Basic Discontinuous Ops | -0.03 | 0.00 | N/A | 0.00 | N/A |
| EPS Diluted Total Ops | 5.95 | 4.11 | N/A | 1.27 | N/A |
| EPS Diluted Continuous Ops | 6.46 | 4.13 | N/A | 1.27 | N/A |
| EPS Diluted Discontinuous Ops | -0.03 | 0.00 | N/A | 0.00 | N/A |
| EBITDA(a) | $346,360 | $70,820 | $N/A | $38,100 | $N/A |